News Archive
July 2021
CEVEC closes growth financing round to serve strong demand in viral vector technologies for cell and gene therapies
CEVEC Pharmaceuticals GmbH (CEVEC), the leading provider of high-performance cell technology for scalable manufacturing of advanced bio-therapeutics, today announced the successful closing of an internal growth financing round.
Emperra's digital diabetes management solution ESYSTA now on prescription
Congratulations to our portfolio company Emperra GmbH E-Health Technologies for the listing of their ESYSTA App as the first Diabetes DiGA and becoming the first broadly reimbursed digital diabetes solution in Germany. This is a major achievement and will help many diabetic patients in their daily life.
Read more … Emperra's digital diabetes management solution ESYSTA now on prescription